YFH-33810-56878
1 vaccination
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 911 / CA
- Registered
- 2021-12-29
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-29
Registered in v-safe
-
2021-12-29
Dose 1 — Pfizer-BioNTech
-
2021-12-29
Survey response — day 0, dose 1MedDRA: Depression, Dyspnoea, Fatigue, Respiratory tract congestion — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Shortness of breathe, tiredness, depression and congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-29 | Pfizer-BioNTech | No |
Free text
Release 10 — day 0, dose 1
Systemic reaction (other): Shortness of breathe, tiredness, depression and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Depression | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release